We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • Cardiovascular
  • Incretins
  • Insulin
  • SGLT2
  • T2 Diabetes
  • Diabetes
  • Blog

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • Cardiovascular
  • Incretins
  • Insulin
  • SGLT2
  • T2 Diabetes
  • Diabetes
  • Blog

SUBSCRIBE: eNewsletter

Endocrine Society Annual Meeting

Coverage of The Endocrine Society's annual meeting, that took place April 1-4 in Orlando, FL.

ENDO 2017

Interesting T2DM: Pharmacotherapy & Obesity Outcomes

  • Julie Bowen
Apr 12, 2017

Our April list includes CV events with DPP-4 or SGLT2 inhibitors vs. insulin, and impact of obesity on nonalcoholic fatty liver disease and thyroid function.

Obesity Management: ENDO 2017 Highlights

  • Mark L. Fuerst
Apr 7, 2017

Could corticosteroid use put your patients at a greater risk of metabolic syndrome?

Endo 2017: Men’s Health

Apr 4, 2017

Men’s health studies presented at ENDO 2017 included a possible prostate cancer treatment and the potential of hormone therapy to prevent frailty.

Endo 2017: Improve Diabetes, Obesity Care

  • Mark L. Fuerst
Apr 4, 2017

Three studies from ENDO 2017 focused on improving patient care through brain stimulation, an artificial pancreas system, and videoconferencing.

Can We Suppress Sugar Cravings?

  • Susan Weimer, DPT, PT
Apr 3, 2017

Researchers sought to discover the specific physiological pathways of fibroblast growth factor 21.

Clinical Dilemmas in Diabetes

  • Susan Weimer, DPT, PT
Apr 3, 2017

Research presented at ENDO 2017 explored options to reduce complications in patients with diabetes and microalbuminuria and patients with cystic fibrosis.

ENDO 2017: Sleep Studies

  • Samantha J. Peterson
Apr 3, 2017

Studies presented at ENDO 2017 examined the impact of sleep disorders on gestational diabetes, bone formation, and adolescents with and without diabetes.

Role of the Striatum in Obesity

  • Susan Weimer, DPT, PT
Apr 2, 2017

Researchers investigated possible differences in the function of the striatum both before and after the development of obesity.

ENDO 2017: Top Sessions

  • Samantha J. Peterson
Mar 31, 2017

You won’t want to miss these top sessions and new features at this year’s Endocrinology Society’s annual meeting, April 1-4, in Orlando, FL.

Resource Topics rightRail

  • Resource Topics
  • Partner Content
ENDO 2017
There is currently no available content. Please check back soon.
Connect with Us
  • Twitter
  • Facebook
  • Google+
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.